Genome-wide Analysis of Single Nucleotide Polymorphisms of Brain Arteriovenous Malformations and Cerebral Aneurysm
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01801488|
Recruitment Status : Terminated (Low enrollment)
First Posted : February 28, 2013
Last Update Posted : November 25, 2015
|Condition or disease|
|Arteriovenous Malformations Intracranial Aneurysm Subarachnoid Hemorrhage|
|Study Type :||Observational|
|Actual Enrollment :||5 participants|
|Observational Model:||Case Control|
|Official Title:||Genome-wide Analysis of Single Nucleotide Polymorphisms of Brain Arteriovenous Malformations and Cerebral Aneurysm|
|Study Start Date :||November 2011|
|Primary Completion Date :||March 2014|
Patients receiving surgical intervention for an intracranial arterial-venous malformation.
Patients receiving surgical intervention for a ruptured intracranial aneurysm.
Patients receiving surgical intervention for an unruptured intracranial aneurysm.
- Risk gene expression [ Time Frame: Within one week of sample collection. ]The samples will be frozen after collection and then analyzed.
Biospecimen Retention: Samples With DNA
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01801488
|United States, New York|
|SUNY Upstate Medical University|
|Syracuse, New York, United States, 13210|
|Principal Investigator:||Eric M Deshaies, MD||SUNY Upstate Medical University Neurosurgery|